IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $408 | -99.9% | 10,811 | -1.7% | 1.03% | -21.3% |
| Q3 2022 | $486,000 | +17.1% | 10,993 | -2.0% | 1.31% | +39.2% |
| Q2 2022 | $415,000 | -16.7% | 11,222 | +35.0% | 0.94% | +84.7% |
| Q3 2019 | $498,000 | -6.7% | 8,314 | 0.0% | 0.51% | -6.2% |
| Q2 2019 | $534,000 | -23.7% | 8,314 | -3.7% | 0.54% | -25.2% |
| Q1 2019 | $700,000 | +59.1% | 8,629 | +6.0% | 0.73% | +22.9% |
| Q4 2018 | $440,000 | +1417.2% | 8,140 | +1118.6% | 0.59% | +2017.9% |
| Q1 2018 | $29,000 | -86.1% | 668 | -83.9% | 0.03% | -86.7% |
| Q4 2017 | $209,000 | +40.3% | 4,154 | +41.1% | 0.21% | +24.3% |
| Q3 2017 | $149,000 | -15.8% | 2,944 | -15.4% | 0.17% | +87.8% |
| Q2 2017 | $177,000 | +28.3% | 3,481 | +1.2% | 0.09% | +18.4% |
| Q1 2017 | $138,000 | -86.2% | 3,440 | -78.7% | 0.08% | -78.1% |
| Q4 2015 | $1,001,000 | – | 16,161 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |